PU08.03 New in vitro release test methods for the dapivirine vaginal ringPublication OnlyDelivery technologies: novel approaches, formulation and multi-purpose
PE09.01 Estimating the market size for a dual prevention pill: adding contraception to PrEP to increase uptake and adherenceE-posterDemand creation, market research, human-centred design
PE09.02 Bridging the insight to action gap: using HCD methods to design organizational tools for stakeholders in South Africa in order to improve effectiveness of AGYW prevention programsE-posterDemand creation, market research, human-centred design
PE09.03 Understanding HIV prevention from the perspective of adolescent girls and young women at high risk of HIV infectionE-posterDemand creation, market research, human-centred design
PU09.01 'If I knew about that, I wouldn't have stopped': increasing flexibility in PrEP use as a key to getting and keeping men on PrEPPublication OnlyDemand creation, market research, human-centred design
PU09.02 'PrEP makes HIV irrelevant': The effect of PrEP on reducing HIV stigmaPublication OnlyDemand creation, market research, human-centred design
OA21.02 Methadone program participation and current ART use among people who inject drugs in KenyaOral Abstract SessionDiscovery and evaluation of biomedical agents
PE11.02 Switching from F/TDF to F/TAF for HIV Pre-exposure Prophylaxis: An Analysis of the Real-World DataE-posterDiscovery and evaluation of biomedical agents
PE11.03 Age-Disparate Sex Partnerships and HIV Infection among Adolescent Girls and Young Women in MalawiE-posterDiscovery and evaluation of biomedical agents
OA02.01 Profiling the HIV epidemic with recency of infection instead of recency of diagnosis: 2 years of experience in North Carolina, USAOral Abstract SessionEpidemiology of HIV
seek-warrow-warrow-eseek-e201 - 210 of 444 items